News
Print PDF

DEA to Restrict Imports and Exports of Synthetic Opioid

Tuesday, June 30, 2020
Sandler, Travis & Rosenberg Trade Report

The Drug Enforcement Administration has announced its intent to issue an order temporarily including the following synthetic opioid into schedule I of the Controlled Substances Act.

- N,N-diethyl-2-(2-(4isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (commonly known as isotonitazene), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever their existence is possible

Once issued, the temporary scheduling order will impose the regulatory controls under the CSA on the importation, exportation, manufacture, distribution, reverse distribution, possession, research and conduct of instructional activities, and chemical analysis of this substance as well as the administrative, civil, and criminal penalties that apply to persons who fail to comply with such controls or otherwise violate the CSA with respect to these substances. This order will be effective no earlier than July 20 and remain in effect for two years, with a possible extension of one year.

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines